Description
Cartalax | Short Peptide Bioregulator – Research Peptide
Cartalax is a short synthetic peptide bioregulator belonging to the Khavinson class of low-molecular-weight regulatory peptides. It is supplied as a lyophilized powder for laboratory investigation.
Research on short peptide bioregulators has centred on their proposed interaction with chromatin and their use as tool compounds in gene-expression and connective-tissue model systems. Cartalax itself remains sparsely characterised in the peer-reviewed literature, and published work in this class is largely preclinical.
Common research applications: peptide bioregulator research, gene-expression model systems, and connective-tissue research models.
Specifications
| Compound | Cartalax |
|---|---|
| Quantity | 20mg per vial |
| Purity | 99%+ (HPLC/MS) |
| Form | Lyophilized powder |
| Storage | Store lyophilized at minus 20 C, protect from light. |
Frequently Asked Questions
What is Cartalax?
Cartalax is a short synthetic peptide bioregulator from the Khavinson class of low-molecular-weight regulatory peptides.
What is Cartalax studied for?
Research interest centres on peptide bioregulator mechanisms and connective-tissue model systems, though the published evidence base for this class is largely preclinical. All work is laboratory research only.
What purity is Cartalax 20mg supplied at?
It is supplied as lyophilized powder at 99%+ purity, verified by independent HPLC and mass spectrometry testing.
For Research Use Only
This material is intended strictly for laboratory and research purposes. It is not intended for human or veterinary use, diagnosis, treatment, or consumption. By purchasing, the buyer confirms they are a qualified researcher and agrees to handle this product in compliance with all applicable regulations.
Reviews
There are no reviews yet.